Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.

Biogen will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as it seeks to expand its presence in the U.S. amid President Donald Trump's ...

Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The upcoming investment in the state’s Research Triangle Park (RTP), where Biogen ...

Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage clinical pipeline support.

The importance of a homegrown biomanufacturing workforce to North Carolina’s swiftly growing life sciences industry was a ...

North Carolina’s RTP is home to Biogen's largest manufacturing footprint. As the state's largest biotechnology employer and one of the top five biopharmaceutical employers, Biogen employs over ...

Biogen employs over 1,500 manufacturing and technical employees in North Carolina, plus more than 400 skilled contractors across its Wake County and Durham County campuses. The company states that ...

Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S. amid President Donald Trump's tariff threats.

The drugmaker has invested about $10 billion in its North Carolina manufacturing to date. It has seven factories in the state with an eighth expected to start working in the second half of 2025.